This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (1046)  • Contact me when this article is cited  Related Content  • Related letter  • Related article  • Similar articles in JAMA  Topic Collections  • Evidence-Based Medicine  • Review  • Alert me on articles by topic

A Meta-analysis of Prospective Studies

Jason Lazarou, MSc; Bruce H. Pomeranz, MD, PhD; Paul N. Corey, PhD

JAMA. 1998;279:1200-1205.

Objective.— To estimate the incidence of serious and fatal adverse drug reactions (ADR) in hospital patients.

Data Sources.— Four electronic databases were searched from 1966 to 1996.

Study Selection.— Of 153, we selected 39 prospective studies from US hospitals.

Data Extraction.— Data extracted independently by 2 investigators were analyzed by a random-effects model. To obtain the overall incidence of ADRs in hospitalized patients, we combined the incidence of ADRs occurring while in the hospital plus the incidence of ADRs causing admission to hospital. We excluded errors in drug administration, noncompliance, overdose, drug abuse, therapeutic failures, and possible ADRs. Serious ADRs were defined as those that required hospitalization, were permanently disabling, or resulted in death.

Data Synthesis.— The overall incidence of serious ADRs was 6.7% (95% confidence interval [CI], 5.2%-8.2%) and of fatal ADRs was 0.32% (95% CI, 0.23%-0.41%) of hospitalized patients. We estimated that in 1994 overall 2216000 (1721000-2711000) hospitalized patients had serious ADRs and 106000 (76000-137000) had fatal ADRs, making these reactions between the fourth and sixth leading cause of death.

Conclusions.— The incidence of serious and fatal ADRs in US hospitals was found to be extremely high. While our results must be viewed with circumspection because of heterogeneity among studies and small biases in the samples, these data nevertheless suggest that ADRs represent an important clinical issue.

From the Departments of Zoology (Mr Lazarou and Dr Pomeranz), Physiology (Dr Pomeranz), and Public Health Sciences (Dr Corey), University of Toronto, Toronto, Ontario.

RELATED LETTER

Formal Education About Medication Errors in Internal Medicine Clerkships
Curtis J. Rosebraugh, Peter K. Honig, Sally Usdin Yasuda, John C. Pezzullo, David A. Flockhart, and Raymond L. Woosley
JAMA. 2001;286(9):1019-1020.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Drugs and Adverse Drug Reactions: How Worried Should We Be?
David W. Bates
JAMA. 1998;279(15):1216-1217.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pharmacogenetics in Ovarian Stimulation--Current Concepts
LOUTRADIS et al.
Ann. N. Y. Acad. Sci. 2008;1127:10-19.
ABSTRACT | FULL TEXT  

An Examination of Factors Related To Radiation Protection Practices
SLECHTA and REAGAN
radtech 2008;79:297-305.
ABSTRACT | FULL TEXT  

Turning the gene tap off; implications of regulating gene expression for cancer therapeutics
Curtin et al.
Molecular Cancer Therapeutics 2008;7:439-448.
ABSTRACT | FULL TEXT  

Inappropriate prescribing in the older population: need for new criteria
O'Mahony and Gallagher
Age Ageing 2008;37:138-141.
ABSTRACT | FULL TEXT  

Nationwide Survey of Subjectively Reported Adverse Drug Reactions in Sweden
Isacson et al.
The Annals of Pharmacotherapy 2008;42:347-353.
ABSTRACT | FULL TEXT  

Inappropriate prescribing in an acutely ill population of elderly patients as determined by Beers' Criteria
Gallagher et al.
Age Ageing 2008;37:96-101.
ABSTRACT | FULL TEXT  

Impact of Computerized Prescriber Order Entry on the Incidence of Adverse Drug Events in Pediatric Inpatients
Holdsworth et al.
Pediatrics 2007;120:1058-1066.
ABSTRACT | FULL TEXT  

Silent Polymorphisms Speak: How They Affect Pharmacogenomics and the Treatment of Cancer
Sauna et al.
Cancer Res. 2007;67:9609-9612.
ABSTRACT | FULL TEXT  

Serious Adverse Drug Events Reported to the Food and Drug Administration, 1998-2005
Moore et al.
Arch Intern Med 2007;167:1752-1759.
ABSTRACT | FULL TEXT  

Admissions to a medical intensive care unit related to adverse drug reactions
Rivkin
Am J Health Syst Pharm 2007;64:1840-1843.
ABSTRACT | FULL TEXT  

Genotypic Approaches to Therapy in Children: A National Active Surveillance Network (GATC) to Study the Pharmacogenomics of Severe Adverse Drug Reactions in Children
ROSS et al.
Ann. N. Y. Acad. Sci. 2007;1110:177-192.
ABSTRACT | FULL TEXT  

Potential drug-drug interactions within Veterans Affairs medical centers
Mahmood et al.
Am J Health Syst Pharm 2007;64:1500-1505.
ABSTRACT | FULL TEXT  

Evaluation of Outpatient Computerized Physician Medication Order Entry Systems: A Systematic Review
Eslami et al.
J. Am. Med. Inform. Assoc. 2007;14:400-406.
ABSTRACT | FULL TEXT  

The Utility of Adding Retrospective Medication Profiling to Computerized Provider Order Entry in an Ambulatory Care Population
Glassman et al.
J. Am. Med. Inform. Assoc. 2007;14:424-431.
ABSTRACT | FULL TEXT  

A Systematic Review of the Performance Characteristics of Clinical Event Monitor Signals Used to Detect Adverse Drug Events in the Hospital Setting
Handler et al.
J. Am. Med. Inform. Assoc. 2007;14:451-458.
ABSTRACT | FULL TEXT  

ASHP Long-Range Vision for the Pharmacy Work Force in Hospitals and Health Systems: Ensuring the Best Use of Medicines in Hospitals and Health Systems
Am J Health Syst Pharm 2007;64:1320-1330.
FULL TEXT  

Evaluation of Serious Adverse Drug Reactions: A Proactive Pharmacovigilance Program (RADAR) vs Safety Activities Conducted by the Food and Drug Administration and Pharmaceutical Manufacturers
Bennett et al.
Arch Intern Med 2007;167:1041-1049.
ABSTRACT | FULL TEXT  

The role of communication in paediatric drug safety
Stebbing et al.
Arch. Dis. Child. 2007;92:440-445.
ABSTRACT | FULL TEXT  

Drug-Induced Sweet's Syndrome
Thompson and Montarella
The Annals of Pharmacotherapy 2007;41:802-811.
ABSTRACT | FULL TEXT  

Managing Complex Medication Regimens: Perspectives of Consumers with Osteoarthritis and Healthcare Professionals
Manias et al.
The Annals of Pharmacotherapy 2007;41:764-771.
ABSTRACT | FULL TEXT  

Pharmacists versus nonpharmacists in adverse drug event detection: A meta-analysis and systematic review
Phansalkar et al.
Am J Health Syst Pharm 2007;64:842-849.
ABSTRACT | FULL TEXT  

Multidisciplinary approach to inpatient medication reconciliation in an academic setting
Varkey et al.
Am J Health Syst Pharm 2007;64:850-854.
ABSTRACT | FULL TEXT  

An ounce of prevention: A pound of cure for an ailing health care system
Genuis
cfp 2007;53:597-599.
FULL TEXT  

Une once de prevention: Prescription pour un systeme de sante en dif_culte
Genuis
cfp 2007;53:605-607.
FULL TEXT  

Pharmaceutical Care in Community Pharmacies: Practice and Research in Denmark
Herborg et al.
The Annals of Pharmacotherapy 2007;41:681-689.
ABSTRACT | FULL TEXT  

Role of the Kupffer Cell in Mediating Hepatic Toxicity and Carcinogenesis
Roberts et al.
Toxicol Sci 2007;96:2-15.
ABSTRACT | FULL TEXT  

The in Vitro Drug Interaction Potential of Dietary Supplements Containing Multiple Herbal Components
Foti et al.
Drug Metab. Dispos. 2007;35:185-188.
ABSTRACT | FULL TEXT  

The Pregnane X Receptor Gene-Humanized Mouse: A Model for Investigating Drug-Drug Interactions Mediated by Cytochromes P450 3A
Ma et al.
Drug Metab. Dispos. 2007;35:194-200.
ABSTRACT | FULL TEXT  

Escalating polypharmacy
Gorard
QJM 2006;99:797-800.
ABSTRACT | FULL TEXT  

The FDA and drug safety: a proposal for sweeping changes.
Furberg et al.
Arch Intern Med 2006;166:1938-1942.
ABSTRACT | FULL TEXT  

Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer.
Hassett et al.
JNCI J Natl Cancer Inst 2006;98:1108-1117.
ABSTRACT | FULL TEXT  

Adverse Drug Reactions Among Children Over a 10-Year Period
Le et al.
Pediatrics 2006;118:555-562.
ABSTRACT | FULL TEXT  

Genetic testing in cancer therapeutics.
Ezzeldin and Diasio
Clin. Cancer Res. 2006;12:4137-4141.
FULL TEXT  

Enhanced Xenobiotic-Induced Hepatotoxicity and Kupffer Cell Activation by Restraint-Induced Stress
Panuganti et al.
J. Pharmacol. Exp. Ther. 2006;318:26-34.
ABSTRACT | FULL TEXT  

Metabolism of Efavirenz and 8-Hydroxyefavirenz by P450 2B6 Leads to Inactivation by Two Distinct Mechanisms
Bumpus et al.
J. Pharmacol. Exp. Ther. 2006;318:345-351.
ABSTRACT | FULL TEXT  

Drug Dosage Adjustments According to Renal Function at Hospital Discharge
van Dijk et al.
The Annals of Pharmacotherapy 2006;40:1254-1260.
ABSTRACT | FULL TEXT  

Adverse Drug Event Reporting in Intensive Care Units: A Survey of Current Practices
Kane-Gill and Devlin
The Annals of Pharmacotherapy 2006;40:1267-1273.
ABSTRACT | FULL TEXT  

Effect of internal reporting criteria on suspected adverse drug reactions submitted to MedWatch
Smith et al.
Am J Health Syst Pharm 2006;63:949-952.
FULL TEXT  

Pharmacogenomics: from bedside to clinical practice.
Marsh and McLeod
Hum Mol Genet 2006;15:R89-R93.
ABSTRACT | FULL TEXT  

The Development and Evaluation of an Integrated Electronic Prescribing and Drug Management System for Primary Care
Tamblyn et al.
J. Am. Med. Inform. Assoc. 2006;13:148-159.
ABSTRACT | FULL TEXT  

Adherence to black box warnings for prescription medications in outpatients.
Lasser et al.
Arch Intern Med 2006;166:338-344.
ABSTRACT | FULL TEXT  

Antibiotic Allergy
Gruchalla and Pirmohamed
NEJM 2006;354:601-609.
FULL TEXT  

Where now for pharmacist led medication review?
Holland et al.
J. Epidemiol. Community Health 2006;60:92-93.
FULL TEXT  

Improving the accuracy of patient identification in the medication-use process
Trapskin et al.
Am J Health Syst Pharm 2006;63:218-222.
FULL TEXT  

Suboptimal Medication Use and Mortality in an Older Adult Community-Based Cohort: Results From the Hispanic EPESE Study.
Espino et al.
J. Gerontol. A Biol. Sci. Med. Sci. 2006;61:170-175.
ABSTRACT | FULL TEXT  

Adverse Drug Reactions in a Department of Pediatric Surgery
Farrokhi et al.
J Trop Pediatr 2006;52:72-73.
FULL TEXT  

Relationship of Medication Use to Health-Related Quality of Life Among a Group of Older American Indians
Henderson et al.
Journal of Applied Gerontology 2006;25:89S-104S.
ABSTRACT  

Interethnic Differences in Genetic Polymorphisms of CYP2D6 in the U.S. Population: Clinical Implications.
Bernard et al.
The Oncologist 2006;11:126-135.
ABSTRACT | FULL TEXT  

Racializing Drug Design: Implications of Pharmacogenomics for Health Disparities
Lee
Am. J. Public Health 2005;95:2133-2138.
ABSTRACT | FULL TEXT  

AUTOMATED ASSESSMENT OF TIME-DEPENDENT INHIBITION OF HUMAN CYTOCHROME P450 ENZYMES USING LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY ANALYSIS
Atkinson et al.
Drug Metab. Dispos. 2005;33:1637-1647.
ABSTRACT | FULL TEXT  

Adverse Drug Reactions in Hospitalized Children in a Department of Infectious Diseases
Fattahi et al.
J Clin Pharmacol 2005;45:1313-1318.
FULL TEXT  

Identification of Inappropriate Drug Prescribing by Computerized, Retrospective DUR Screening in Korea
Yeom et al.
The Annals of Pharmacotherapy 2005;39:1918-1923.
ABSTRACT | FULL TEXT  

Pharmacogenetics/genomics and personalized medicine
Sadee and Dai
Hum Mol Genet 2005;14:R207-R214.
ABSTRACT | FULL TEXT  

Drug-Related Visits to the Emergency Department
Zed
Journal of Pharmacy Practice 2005;18:329-335.
ABSTRACT  

Adverse Drug Reactions and Avalanches: Life at the Edge of Chaos
Frattarelli
J Clin Pharmacol 2005;45:866-871.
ABSTRACT | FULL TEXT  

The Efficacy and Safety of Pain Management Before and After Implementation of Hospital-Wide Pain Management Standards: Is Patient Safety Compromised by Treatment Based Solely on Numerical Pain Ratings?
Vila et al.
Anesth. Analg. 2005;101:474-480.
ABSTRACT | FULL TEXT  

Accuracy of adverse-drug-event reports collected using an automated dispensing system
Romero and Malone
Am J Health Syst Pharm 2005;62:1375-1380.
ABSTRACT | FULL TEXT  

Epidemiology, Comparative Methods of Detection, and Preventability of Adverse Drug Events
Al-Tajir and Kelly
The Annals of Pharmacotherapy 2005;39:1169-1174.
ABSTRACT | FULL TEXT  

Pharmacogenomics: Harbinger for the Era of Personalized Medicine?
Sadee
Mol. Interv. 2005;5:140-143.
FULL TEXT  

Challenging times for food allergy tests
Roberts
Arch. Dis. Child. 2005;90:564-566.
FULL TEXT  

Drug Metabolism and Variability among Patients in Drug Response
Wilkinson
NEJM 2005;352:2211-2221.
FULL TEXT  

Five Years After To Err Is Human: What Have We Learned?
Leape and Berwick
JAMA 2005;293:2384-2390.
ABSTRACT | FULL TEXT  

The Research on Adverse Drug Events and Reports (RADAR) Project
Bennett et al.
JAMA 2005;293:2131-2140.
ABSTRACT | FULL TEXT  

Concealed Renal Insufficiency and Adverse Drug Reactions in Elderly Hospitalized Patients
Corsonello et al.
Arch Intern Med 2005;165:790-795.
ABSTRACT | FULL TEXT  

Service utilization in 1896 and 1996: morbidity and mortality data from North Wales
Healy et al.
History of Psychiatry 2005;16:27-41.
ABSTRACT  

Pharmacogenetics, ethical issues: review of the Nuffield Council on Bioethics Report
Corrigan
J. Med. Ethics 2005;31:144-148.
ABSTRACT | FULL TEXT  

Unresolved issues in pharmacy
Zellmer
Am J Health Syst Pharm 2005;62:259-265.
FULL TEXT  

Safety Issues in the Interaction of Conventional, Complementary, and Alternative Health Care
Curtis and Gaylord
Complementary Health Practice Review 2005;10:3-31.
ABSTRACT  

Codeine Intoxication Associated with Ultrarapid CYP2D6 Metabolism
Gasche et al.
NEJM 2004;351:2827-2831.
ABSTRACT | FULL TEXT  

Non-compliance: a side effect of drug information leaflets
Verdu and Castello
J. Med. Ethics 2004;30:608-609.
FULL TEXT  

Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions: A Counterpoint
Strom
JAMA 2004;292:2643-2646.
FULL TEXT  

Patient reports of adverse events associated with acupuncture treatment: a prospective national survey
MacPherson et al.
Qual Saf Health Care 2004;13:349-355.
ABSTRACT | FULL TEXT  

Moving Toward Integrative Care: Rationales, Models, and Steps for Conventional-Care Providers
Mann et al.
Complementary Health Practice Review 2004;9:155-172.
ABSTRACT  

The Tolling of the Bell: Women's Health, Women's Rights
Dickerson
Obstet Gynecol 2004;104:653-657.
FULL TEXT  

Antidepressants: An Avoidable and Solvable Controversy
Cohen
The Annals of Pharmacotherapy 2004;38:1743-1746.
FULL TEXT  

A Drug Database Model as a Central Element for Computer-Supported Dose Adjustment within a CPOE System
Martin et al.
J. Am. Med. Inform. Assoc. 2004;11:427-432.
ABSTRACT | FULL TEXT  

Pharmacogenomics and Pharmacogenetics: Future Role of Molecular Diagnostics in the Clinical Diagnostic Laboratory
Ito and Demers
Clin. Chem. 2004;50:1526-1527.
FULL TEXT  

Service innovations: Pharmacogenetic clinics in psychiatry: a clinical reality?
Hodgson et al.
Psychiatr. Bull. 2004;28:298-300.
ABSTRACT | FULL TEXT  

Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients
Pirmohamed et al.
BMJ 2004;329:15-19.
ABSTRACT | FULL TEXT  

Open letter to Annette King, Minister of Health, New Zealand
Herxheimer
BMJ 2004;329:51-51.
FULL TEXT  

Direct reporting of suspected adverse drug reactions by patients
Choonara
JRSM 2004;97:316-317.
FULL TEXT  

Using a Computerized Drug Prescription Screening System to Trace Drug Interactions in an Outpatient Setting
Morera et al.
The Annals of Pharmacotherapy 2004;38:1301-1306.
ABSTRACT | FULL TEXT  

Using Pharmacogenetics to Improve Drug Safety and Efficacy
Haga and Burke
JAMA 2004;291:2869-2871.
FULL TEXT  

Herbal Remedies in the United States: Potential Adverse Interactions With Anticancer Agents
Sparreboom et al.
JCO 2004;22:2489-2503.
ABSTRACT | FULL TEXT  

VALIDATED ASSAYS FOR HUMAN CYTOCHROME P450 ACTIVITIES
Walsky and Obach
Drug Metab. Dispos. 2004;32:647-660.
ABSTRACT | FULL TEXT  

Medication Errors in Family Practice, in Hospitals and After Discharge from the Hospital An Ethical Analysis
Clark
J Law Med Ethics 2004;32:349-357.
 

Aging Biology and Geriatric Clinical Pharmacology
McLean and Le Couteur
Pharmacol. Rev. 2004;56:163-184.
ABSTRACT | FULL TEXT  

Comparison of Drug-Related Problems in Different Patient Groups
Viktil et al.
The Annals of Pharmacotherapy 2004;38:942-948.
ABSTRACT | FULL TEXT  

Rapid Identification of Dihydropyrimidine Dehydrogenase Deficiency by Using a Novel 2-13C-Uracil Breath Test
Mattison et al.
Clin. Cancer Res. 2004;10:2652-2658.
ABSTRACT | FULL TEXT  

Adverse Events Due to Discontinuations in Drug Use and Dose Changes in Patients Transferred Between Acute and Long-term Care Facilities
Boockvar et al.
Arch Intern Med 2004;164:545-550.
ABSTRACT | FULL TEXT  

Patient Safety Forum: Developing a Strategic Plan: What is a reasonable first-year strategic plan to better address medication errors in psychiatry?
Conway et al.
Psychiatr. Serv. 2004;55:259-263.
ABSTRACT | FULL TEXT  

Pharmacoeconomic analysis of thiopurine methyltransferase polymorphism screening by polymerase chain reaction for treatment with azathioprine in Korea
Oh et al.
Rheumatology (Oxford) 2004;43:156-163.
ABSTRACT | FULL TEXT  

Updating the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults: Results of a US Consensus Panel of Experts
Fick et al.
Arch Intern Med 2003;163:2716-2724.
ABSTRACT | FULL TEXT  

Drug-Induced Esophageal Injuries and Dysphagia
O'Neill and Remington
The Annals of Pharmacotherapy 2003;37:1675-1684.
ABSTRACT | FULL TEXT  

The Impact of Dedicated Medication Nurses on the Medication Administration Error Rate: A Randomized Controlled Trial
Greengold et al.
Arch Intern Med 2003;163:2359-2367.
ABSTRACT | FULL TEXT  

Delayed Drug Hypersensitivity Reactions
Pichler
ANN INTERN MED 2003;139:683-693.
ABSTRACT | FULL TEXT  

Terminology and the Construction of Scientific Disciplines: The Case of Pharmacogenomics
Hedgecoe
Science Technology Human Values 2003;28:513-537.
ABSTRACT  

Inflammation and Drug Idiosyncrasy--Is There a Connection?
Roth et al.
J. Pharmacol. Exp. Ther. 2003;307:1-8.
ABSTRACT | FULL TEXT